$BLGO
BIOLARGO, INC.

2016 Form 10-K Financial Statement

#000143774917005635 Filed on March 30, 2017

View on sec.gov

Income Statement

Concept 2016 2015 Q4 2015
Revenue $281.1K $50.00K $127.6K
YoY Change 120.33% -16.67% 14.37%
Cost Of Revenue $105.9K $30.00K $62.07K
YoY Change 70.59% -25.0% 10.83%
Gross Profit $175.2K $30.00K $65.52K
YoY Change 167.46% 0.0% 17.94%
Gross Profit Margin 62.34% 60.0% 51.35%
Selling, General & Admin $3.714M $680.0K $3.552M
YoY Change 4.59% 17.24% 27.15%
% of Gross Profit 2119.74% 2266.67% 5420.93%
Research & Development $1.382M $220.0K $684.6K
YoY Change 101.88% 37.5% 6.48%
% of Gross Profit 788.66% 733.33% 1044.88%
Depreciation & Amortization $13.74K $0.00 $10.92K
YoY Change 25.79%
% of Gross Profit 7.84% 0.0% 16.67%
Operating Expenses $5.096M $890.0K $4.236M
YoY Change 20.31% 18.67% 22.89%
Operating Profit -$4.935M -$860.0K -$4.181M
YoY Change 18.02% 19.44% 23.3%
Interest Expense $3.129M -$430.0K $994.7K
YoY Change 214.59% 975.0% -385.7%
% of Operating Profit
Other Income/Expense, Net -$3.139M $40.00K $99.12K
YoY Change -3267.35%
Pretax Income -$8.074M -$1.260M -$5.077M
YoY Change 59.04% 65.79% 35.77%
Income Tax
% Of Pretax Income
Net Earnings -$8.074M -$1.250M -$5.077M
YoY Change 59.04% 68.92% 37.51%
Net Earnings / Revenue -2872.35% -2500.0% -3979.42%
Basic Earnings Per Share
Diluted Earnings Per Share -$89.15K -$14.60K -$60.11K
COMMON SHARES
Basic Shares Outstanding 87.94M 84.11M
Diluted Shares Outstanding

Balance Sheet

Concept 2016 2015 Q4 2015
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.910M $1.760M $1.763M
YoY Change 8.34% 1073.33% 1041.47%
Cash & Equivalents $1.910M $1.763M $1.763M
Short-Term Investments
Other Short-Term Assets $4.090K $50.00K $49.17K
YoY Change -91.68% 0.0% 9.27%
Inventory $34.45K $37.44K $37.44K
Prepaid Expenses $49.17K
Receivables $67.99K $41.43K $41.43K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.017M $1.891M $1.891M
YoY Change 6.64% 722.24% 720.14%
LONG-TERM ASSETS
Property, Plant & Equipment $59.32K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $36.73K $19.16K $19.16K
YoY Change 91.7% -36.14% -36.3%
Total Long-Term Assets $96.05K $19.16K $19.15K
YoY Change 401.57% -36.14% -36.34%
TOTAL ASSETS
Total Short-Term Assets $2.017M $1.891M $1.891M
Total Long-Term Assets $96.05K $19.16K $19.15K
Total Assets $2.113M $1.910M $1.910M
YoY Change 10.6% 634.73% 632.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $200.1K $174.5K $325.0K
YoY Change -38.43% -43.7%
Accrued Expenses $80.00K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $50.00K $0.00 $0.00
YoY Change
Long-Term Debt Due $161.1K $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $1.155M $460.0K $460.0K
YoY Change 151.04% -29.23% -29.55%
LONG-TERM LIABILITIES
Long-Term Debt $1.728M $3.246M $309.0K
YoY Change 459.37%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.728M $3.246M $309.0K
YoY Change 459.37%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.155M $460.0K $460.0K
Total Long-Term Liabilities $1.728M $3.246M $309.0K
Total Liabilities $3.438M $768.9K $1.559M
YoY Change 120.59% 8.3% 118.41%
SHAREHOLDERS EQUITY
Retained Earnings -$84.08M
YoY Change
Common Stock $57.24K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.325M $351.8K $351.8K
YoY Change
Total Liabilities & Shareholders Equity $2.113M $1.910M $1.910M
YoY Change 10.6% 634.73% 632.84%

Cashflow Statement

Concept 2016 2015 Q4 2015
OPERATING ACTIVITIES
Net Income -$8.074M -$1.250M -$5.077M
YoY Change 59.04% 68.92% 37.51%
Depreciation, Depletion And Amortization $13.74K $0.00 $10.92K
YoY Change 25.79%
Cash From Operating Activities -$3.721M -$540.0K -$1.883M
YoY Change 97.57% 80.0% 9.58%
INVESTING ACTIVITIES
Capital Expenditures -$61.93K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$61.93K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.971M 1.780M 3.533M
YoY Change 12.41% 493.33% 98.39%
NET CHANGE
Cash From Operating Activities -3.721M -540.0K -1.883M
Cash From Investing Activities -61.93K
Cash From Financing Activities 3.971M 1.780M 3.533M
Net Change In Cash 188.2K 1.240M 1.649M
YoY Change -88.59% 2559.17%
FREE CASH FLOW
Cash From Operating Activities -$3.721M -$540.0K -$1.883M
Capital Expenditures -$61.93K
Free Cash Flow -$3.659M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q4 blgo Accrued Payroll Taxes Possible Reduced Amount
AccruedPayrollTaxesPossibleReducedAmount
5000
CY2016Q4 blgo Capitalization Equity
CapitalizationEquity
158139714
CY2015 blgo Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
CY2016 blgo Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
2818271
CY2015 blgo Class Of Warrant Or Right Expirations During Period
ClassOfWarrantOrRightExpirationsDuringPeriod
7752079
CY2016 blgo Class Of Warrant Or Right Expirations During Period
ClassOfWarrantOrRightExpirationsDuringPeriod
2383545
CY2015 blgo Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
12693395
CY2016 blgo Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
6822855
CY2016 blgo Class Of Warrant Or Right Prior Year Extensions
ClassOfWarrantOrRightPriorYearExtensions
4634637
CY2016 blgo Class Of Warrant Or Right Prior Year Extensions Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightPriorYearExtensionsExercisePriceOfWarrantsOrRights
0.30
CY2016Q4 blgo Common Stock Options And Warrants Outstanding Total
CommonStockOptionsAndWarrantsOutstandingTotal
143076436
CY2015Q4 blgo Consulting Services Monthly Payment
ConsultingServicesMonthlyPayment
23438
CY2015Q4 blgo Consulting Services Period Of Services
ConsultingServicesPeriodOfServices
P4Y
CY2015Q4 blgo Discount On Convertible Notes Payable Current
DiscountOnConvertibleNotesPayableCurrent
CY2016Q4 blgo Discount On Convertible Notes Payable Current
DiscountOnConvertibleNotesPayableCurrent
398910
CY2015Q4 blgo Discount On Convertible Notes Payable Net Of Current Portion
DiscountOnConvertibleNotesPayableNetOfCurrentPortion
2937019
CY2016Q4 blgo Discount On Convertible Notes Payable Net Of Current Portion
DiscountOnConvertibleNotesPayableNetOfCurrentPortion
3522497
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-12-31
CY2016 dei Document Type
DocumentType
10-K
CY2016Q2 dei Entity Public Float
EntityPublicFloat
23993345
CY2015Q3 blgo Line Of Credit Facility Canceled
LineOfCreditFacilityCanceled
58530
CY2015 blgo Other Income And Expenses Net
OtherIncomeAndExpensesNet
-895549
CY2016 blgo Other Income And Expenses Net
OtherIncomeAndExpensesNet
-3139474
CY2015 blgo Proceeds From Sale Of Convertible Notes Payable
ProceedsFromSaleOfConvertibleNotesPayable
2804713
CY2016 blgo Proceeds From Sale Of Convertible Notes Payable
ProceedsFromSaleOfConvertibleNotesPayable
2307000
CY2016Q4 blgo Shares Issuable Upon Conversion Of Debt
SharesIssuableUponConversionOfDebt
15063278
CY2016 blgo Stock Issued During Period Shares Exercise Of Warrants
StockIssuedDuringPeriodSharesExerciseOfWarrants
2818271
CY2015 blgo Stock Issued During Period Value Conversion Of Equity To Debt
StockIssuedDuringPeriodValueConversionOfEquityToDebt
212017
CY2016 blgo Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
864009
CY2015 blgo Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
CY2016 blgo Valuation Allowance Percentage
ValuationAllowancePercentage
1
CY2016Q4 blgo Working Capital
WorkingCapital
861929
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
324983
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
200103
CY2015Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
324983
CY2016Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
280103
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
174539
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
22231
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
41431
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
67994
CY2016Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
80000
CY2015Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
CY2015Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
137500
CY2016Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
137500
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-40567
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-81694
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
84410821
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
90609774
CY2015 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1831313
CY2016 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
751113
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3818
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2015 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
808572
CY2016 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2610764
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10920
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10920
CY2015Q4 us-gaap Assets
Assets
1910304
CY2016Q4 us-gaap Assets
Assets
2112726
CY2016Q4 us-gaap Assets Current
AssetsCurrent
2016682
CY2015Q4 us-gaap Assets Current
AssetsCurrent
1891147
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1910153
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
154460
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1763114
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1608654
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
147039
CY2016Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
20035114
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
8838122
CY2015Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
13779438
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00067
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00067
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
85648015
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
92975970
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
92975970
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
57236
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
62179
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5096543
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7880858
CY2015 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-21054
CY2016 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-234604
CY2015 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-5117597
CY2016 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-8115462
CY2015Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
3245972
CY2016Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
5250668
CY2015Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
CY2016Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
560000
CY2015 us-gaap Cost Of Revenue
CostOfRevenue
62067
CY2016 us-gaap Cost Of Revenue
CostOfRevenue
105877
CY2015Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
135000
CY2016Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
CY2015Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.25
CY2015 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10920
CY2016 us-gaap Depreciation And Amortization
DepreciationAndAmortization
15887
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10920
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13736
CY2015Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
CY2016Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
663560
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2015 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-40567
CY2016 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-41127
CY2015 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
CY2016 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
171800
CY2016 us-gaap Interest Expense
InterestExpense
3129104
CY2015 us-gaap Interest Expense Debt
InterestExpenseDebt
994671
CY2015 us-gaap Gross Profit
GrossProfit
65515
CY2016 us-gaap Gross Profit
GrossProfit
175229
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
4000
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
7681
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-110554
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-124880
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
35814
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
26563
CY2015 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
35000
CY2016 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-135000
CY2015 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
CY2016 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
80000
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
11921
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2989
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4167
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-14235
CY2015 us-gaap Interest Expense
InterestExpense
994671
CY2016 us-gaap Interest Expense Debt
InterestExpenseDebt
3129104
CY2015 us-gaap Interest Paid
InterestPaid
9855
CY2016 us-gaap Interest Paid
InterestPaid
CY2015Q4 us-gaap Interest Payable Current
InterestPayableCurrent
12944
CY2016Q4 us-gaap Interest Payable Current
InterestPayableCurrent
40372
CY2015Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
25273
CY2016Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
19891
CY2015Q4 us-gaap Inventory Net
InventoryNet
37435
CY2016Q4 us-gaap Inventory Net
InventoryNet
34446
CY2015Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
12162
CY2016Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
14555
CY2015 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
670339
CY2016 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
993078
CY2015Q4 us-gaap Liabilities
Liabilities
768936
CY2016Q4 us-gaap Liabilities
Liabilities
2882924
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1910304
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2112726
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
459983
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1154753
CY2013Q4 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.24
CY2016Q2 us-gaap Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
0.18
CY2016Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
50000
CY2015Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
5860668
CY2015Q4 us-gaap Long Term Debt
LongTermDebt
3245972
CY2015Q4 us-gaap Minority Interest
MinorityInterest
789573
CY2016Q4 us-gaap Minority Interest
MinorityInterest
554969
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3971009
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3532563
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-61931
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1883342
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3720912
CY2015 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-21054
CY2016 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-234604
CY2015 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5055976
CY2016 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7839731
CY2015 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
750000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-4181481
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-4934861
CY2016Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
45000000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
19157
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00067
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2015 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
750000
CY2016 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
CY2016Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
300000
CY2015 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
CY2016 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
300000
CY2013Q4 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
50000
CY2015 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
CY2016 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
500000
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
49167
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4089
CY2015 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
CY2016 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
864009
CY2016 us-gaap Profit Loss
ProfitLoss
-8074335
CY2015 us-gaap Profit Loss
ProfitLoss
-5077030
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
59315
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
36729
CY2015 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-40567
CY2016 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-41127
CY2015 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
22150
CY2016 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
CY2015 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
CY2016 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
61931
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00067
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
684554
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1381956
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-91915426
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-84075695
CY2015 us-gaap Revenue From Grants
RevenueFromGrants
99122
CY2016 us-gaap Revenue From Grants
RevenueFromGrants
161430
CY2016 us-gaap Revenues
Revenues
281106
CY2015 us-gaap Royalty Revenue
RoyaltyRevenue
CY2016 us-gaap Royalty Revenue
RoyaltyRevenue
55000
CY2015 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
127582
CY2016 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
226106
CY2015 us-gaap Sales Revenue Net
SalesRevenueNet
127582
CY2016 us-gaap Sales Revenue Net
SalesRevenueNet
281106
CY2016 us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
2167420
CY2015 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
64559
CY2016 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
589371
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
351795
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-1325167
CY2015 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3551522
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3714398
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
1831313
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
751113
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
30065352
CY2016Q4 us-gaap Share Price
SharePrice
0.83
CY2015 us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
258236
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-392270
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1141368
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-770198
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-style: italic;">Use of Estimates </div></div></div></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and revenues and expenses during the period reported. Actual results could differ from those estimates. Estimates are used when accounting for stock-based transactions, debt transactions, derivative liabilities, allowance for bad debt, asset depreciation and amortization, and payroll taxes, among others. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The methods, estimates and judgments we use in applying these most critical accounting policies have a significant impact on the results of our financial statements.</div></div></div></div></div>
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84112356
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87936783

Files In Submission

Name View Source Status
0001437749-17-005635-index-headers.html Edgar Link pending
0001437749-17-005635-index.html Edgar Link pending
0001437749-17-005635.txt Edgar Link pending
0001437749-17-005635-xbrl.zip Edgar Link pending
blgo-20161231.xml Edgar Link completed
blgo-20161231.xsd Edgar Link pending
blgo-20161231_cal.xml Edgar Link unprocessable
blgo-20161231_def.xml Edgar Link unprocessable
blgo-20161231_lab.xml Edgar Link unprocessable
blgo-20161231_pre.xml Edgar Link unprocessable
blgo20161231_10k.htm Edgar Link pending
ex21-1.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex4-19.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending